Arrythmia, Cardiac
12
1
2
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
17%
2 trials in Phase 3/4
29%
2 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (12)
Arrhythmia in Hemodialysis Patients
StereoTactic Arrhythmia Radiotherapy in the NetherLands no. 2
A Single Center Prospective Study in an Estimated 570 Patients Who Underwent Genetic Screening at UZ Brussel in the Context of a Primary Cardiac Arrhythmia. Patients Showing a Variant Class 3,4 or 5 in SCN4A or CLCN1 Will Undergo a Clinical and Electrophysiological Review After IC.
Cardiovascular Complications in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Atrial Fibrillation Health Literacy and Information Technology Trial
Effect of Empagliflozin on Ventricular Repolarization.
Platelet Transfusion During Neonatal Open Heart Surgery
Hypoglycaemia and Cardiac Arrhythmias in Type 1 Diabetes
Validation Study of the Watch HWA09 and Its Softwares ECG-SW1 and PPG-SW1 for the Detection of Atrial Fibrillation
VitalConnect VitalPatch ECG Interpretation/Arrhythmia Detection
Validation Study of a Watch for the Detection of Atrial Fibrillation
iBeat Wristwatch Validation Study